Clinical considerations for treatment and prophylaxis of mpox infection in people who are immunocompromised
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Query Builder

Query box

Help
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Clinical considerations for treatment and prophylaxis of mpox infection in people who are immunocompromised

Filetype[PDF-461.57 KB]


  • English
    • Details Supporting Files You May Also Like

    Details:

    • Alternative Title:
      Clinical considerations for treatment and prophylaxis of monkeypox virus infection in people with HIV
    • Corporate Authors:
      National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology.
    • Description:
      Updated April 3, 2023

      Patients are still developing severe mpox. A March 3, 2023, MMWR provides updated clinical treatment considerations about using therapeutics to treat severe mpox cases, including ocular infections, neurologic complications, myopericarditis, complications associated with mucosal lesions, and complications from uncontrolled viral spread.

      Updates as of December 13, 2022: Expanded to include considerations for treatment and prophylaxis of mpox virus infection in people with immunocompromising conditions other than HIV.

      Who this is for: Healthcare professionals caring for people who are immunocompromised from HIV or other conditions or who are taking immunosuppressive agents.

      What this is for: Issues to consider when caring for people with or exposed to mpox who are also immunocompromised from a condition or from an immunosuppressive drug.

      How to use: This information may be used to educate staff at healthcare facilities and by healthcare professionals developing mpox treatment and prophylaxis plans for people who have HIV or are immunocompromised or immunosuppressed from other conditions or treatments.

    • Content Notes:
      Mpox in People Who are Immunocompromised -- Diagnosis -- Treatment -- Vaccination.
    • Subjects:
    • Document Type:
      Webpage
    • Collection(s):
    • Main Document Checksum:
    • Download URL:
    • File Type:

    Supporting Files

    More +

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov